Katelyn Hart in Tampa, Florida

Home Florida Tampa

Katelyn Hart has Nurse Practitioner as her primary medical specialty. Their primary office is: 12902 Usf Magnolia Dr in Tampa, Florida.

They're a part of the: H Lee Moffitt Cancer Ctr And Res Inst Life Time Cancer Scrn Ctr Inc medical group which has around 892 members. You can call their office at 888-860-2778 to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended Sorry, her university is not listed and graduated in 2016 (around 8 years of experience). They are listed as doing telehealth appointments.

Katelyn M Hart Office Phone and Directions

Katelyn Hart
H Lee Moffitt Cancer Ctr And Res Inst Life Time Cancer Scrn Ctr Inc
12902 Usf Magnolia Dr
Tampa, Florida 33612
888-860-2778

Patient Ratings
Please rate your experience with Katelyn Hart below to help others make a more informed decision. Thanks!

Current Rating: Loading...

Phone: 888-860-2778

Enter a starting address:

Healthcare Info for Katelyn Hart

Medical School: Sorry, her university is not listed
Graduation Year: 2016
The Primary Medical Specialty for Katelyn Hart is listed as: Nurse Practitioner
Approximate Years of Experience: 8
PAC (PECOS ID)#: 5597043083
NPI #: 1528416393
NPI Created On: 06/02/2016
NPI Last Updated Listed as: 10/19/2022
Primary Taxonomy Code: 363L00000X
License Number:
APRN9336853
Listed Gender: Female

Accepted forms of Insurance

Forms of insurance accepted by include, but are not limited to:

Molina Healthcare of Florida, Inc
Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English.

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.

Payments Total: $3

Number of Payments:: 1

Form of Payment: In-kind items and services

Ownership Interest:

Third party is a Charity:: No

Record ID:: 788354065

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: DARZALEX

Open Associated Drug #1: 57894-502-05

Drug or Biological: Biological

Product Category #2: Oncology

Name Of Drug #2:: IMBRUVICA

Associated Drug #2: 57962-140-09

Payments Total: $15

Number of Payments:: 1

Form of Payment: In-kind items and services

Ownership Interest:

Third party is a Charity:: No

Record ID:: 788354069

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-140-09

Drug or Biological: Drug

Product Category #2: Oncology

Name Of Drug #2:: DARZALEX

Associated Drug #2: 57894-502-05

Payments Total: $14

Number of Payments:: 1

Form of Payment: In-kind items and services

Ownership Interest:

Third party is a Charity:: No

Record ID:: 788354067

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: DARZALEX

Open Associated Drug #1: 57894-502-05

Drug or Biological: Biological

Product Category #2: Oncology

Name Of Drug #2:: IMBRUVICA

Associated Drug #2: 57962-140-09

Payments Total: $0

Number of Payments:: 1

Form of Payment: In-kind items and services

Ownership Interest:

Third party is a Charity:: No

Record ID:: 788354071

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-140-09

Drug or Biological: Drug

Product Category #2: Oncology

Name Of Drug #2:: DARZALEX

Associated Drug #2: 57894-502-05

Payments Total: $14

Number of Payments:: 1

Form of Payment: In-kind items and services

Ownership Interest:

Third party is a Charity:: No

Record ID:: 788354073

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: DARZALEX

Open Associated Drug #1: 57894-502-05

Drug or Biological: Biological

Product Category #2: Oncology

Name Of Drug #2:: IMBRUVICA

Associated Drug #2: 57962-140-09

Payments Total: $16

Number of Payments:: 1

Form of Payment: In-kind items and services

Ownership Interest:

Third party is a Charity:: No

Record ID:: 788354075

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: DARZALEX

Open Associated Drug #1: 57894-502-05

Drug or Biological: Biological

Product Category #2: Oncology

Name Of Drug #2:: IMBRUVICA

Associated Drug #2: 57962-140-09

Payments Total: $14

Number of Payments:: 1

Form of Payment: In-kind items and services

Ownership Interest:

Third party is a Charity:: No

Record ID:: 788354077

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: DARZALEX

Open Associated Drug #1: 57894-502-05

Drug or Biological: Biological

Product Category #2: Oncology

Name Of Drug #2:: IMBRUVICA

Associated Drug #2: 57962-140-09

Payments Total: $11

Number of Payments:: 1

Form of Payment: In-kind items and services

Ownership Interest:

Third party is a Charity:: No

Record ID:: 788354079

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-140-09

Drug or Biological: Drug

Product Category #2: Oncology

Name Of Drug #2:: DARZALEX

Associated Drug #2: 57894-502-05

Payments Total: $9

Number of Payments:: 1

Form of Payment: In-kind items and services

Ownership Interest:

Third party is a Charity:: No

Record ID:: 788354081

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: DARZALEX

Open Associated Drug #1: 57894-502-05

Drug or Biological: Biological

Product Category #2: Oncology

Name Of Drug #2:: IMBRUVICA

Associated Drug #2: 57962-140-09

Payments Total: $15

Number of Payments:: 1

Form of Payment: In-kind items and services

Ownership Interest:

Third party is a Charity:: No

Record ID:: 788354083

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-140-09

Drug or Biological: Drug

Product Category #2: Oncology

Name Of Drug #2:: DARZALEX

Associated Drug #2: 57894-502-05

Nurse Practitioner Professionals in Tampa

1.
Jean Thibault

4600 N Habana Ave
Tampa, FL
St. Joseph's Hospital, Inc.

2.
Leah Majarocon

3030 W Bearss Ave
Tampa, FL
Inpatient Consultants Of Florida, Inc

3.
Lauren Hammer

2818 W Virginia Ave
Tampa, FL
Womens Care Florida Llc

4.
Lauren Hammer

3268 Cove Bend Dr
Tampa, FL
Womens Care Florida Llc

5.
Paul Larson

13901 Bruce B Downs Blvd
Tampa, FL
Florida Hospital Physician Group Inc

6.
Paul Larson

3100 E Fletcher Ave
Tampa, FL
Florida Hospital Physician Group Inc

Providers in H Lee Moffitt Cancer Ctr And Res Inst Life Time Cancer Scrn Ctr Inc

1.Erica Blanche Abanil

12902 Usf Magnolia Dr
Tampa Fl 33612-9416
H Lee Moffitt Cancer Ctr And Res Inst Life Time Cancer Scrn Ctr Inc
Nurse Practitioner

2.Enas Abdallah

12902 Usf Magnolia Dr
Tampa Fl 33612-9416
H Lee Moffitt Cancer Ctr And Res Inst Life Time Cancer Scrn Ctr Inc
Hematology

3.Edith Abraham

12902 Usf Magnolia Dr
Tampa Fl 33612-9416
H Lee Moffitt Cancer Ctr And Res Inst Life Time Cancer Scrn Ctr Inc
Nurse Practitioner

4.Ashraf Abu Hayja

12902 Usf Magnolia Dr
Tampa Fl 33612-9416
H Lee Moffitt Cancer Ctr And Res Inst Life Time Cancer Scrn Ctr Inc
Nurse Practitioner

5.Amal Abukhdeir

12902 Usf Magnolia Dr
Tampa Fl 33612-9416
H Lee Moffitt Cancer Ctr And Res Inst Life Time Cancer Scrn Ctr Inc
Nurse Practitioner

6.Marjorie Acierno

12902 Usf Magnolia Dr
Tampa Fl 33612-9416
H Lee Moffitt Cancer Ctr And Res Inst Life Time Cancer Scrn Ctr Inc
Nurse Practitioner

View all 892 members of H Lee Moffitt Cancer Ctr And Res Inst Life Time Cancer Scrn Ctr Inc medical group